Teva scraps Heptares migraine pact as lead drug nears clinic | FierceBiotech
Xconomy: Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals
Teva pushes further into transdermal patches with $144M NuPathe buy
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Teva Pharmaceutical Industries Ltd. - New research by Teva has thrown a spotlight on how badly affected women are by #migraine. But behind those numbers are real people. Come and meet some
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug | BioSpace
Will Teva's migraine drug help the company overcome its headaches? - STAT
Ajovy, Teva's migraine drug, recommended by UK's NICE.
Teva Migraine Drug Wins FDA Approval | Fortune
EMHA and Teva, Migraine day of Action
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Teva stops selling migraine patches after reports of burns | The Times of Israel
Can Teva Hold Its Own In Bringing Migraine Drugs To Market? | Investor's Business Daily
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... | Business
Teva v. Eli Lilly: Teva argues Lilly is infringing migraine drug patent in the United States - Harvard Journal of Law & Technology
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | FiercePharma
Teva Pharmaceuticals on Twitter: "Migraine is not just a headache. Our migraine expert, Dr Joshua Cohen, explains why it's time to break the stigma. #MigraineandHeadacheAwarenessMonth https://t.co/rD3hXiRVoc https://t.co/b46jYhpZSH" / Twitter
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
U.S. regulator approves Teva migraine drug, shares rise | Reuters
Teva Pharmaceutical Industries Ltd. - Our research has uncovered the extraordinarily disproportionate impact #migraine has on women than men. Meet Ciara and others – the real people behind the numbers – and
Teva's migraine prophylaxis drug now approved in Europe
Areas of care treated by Teva. (Sources: 1 Teva treatment for migraine,... | Download Scientific Diagram
Teva migraine medicine gets EU positive opinion
Faint hope for Alder as Teva bucks dismal migraine trend | Evaluate
Xconomy: Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results
Eli Lilly avoids sanctions in Teva migraine treatment dispute
